Skip to content

Clinical observation on improvement of shoulder pain and upper limb motor function in patients with hemiplegia after stroke by electroacupuncture combined with high-frequency repetitive transcranial magnetism

Clinical observation on improvement of shoulder pain and upper limb motor function in patients with hemiplegia after stroke by electroacupuncture combined with high-frequency repetitive transcranial magnetism

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068963
Enrollment
Unknown
Registered
2023-03-02
Start date
2023-03-10
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, hemiplegia, shoulder pain

Interventions

The curative group:Conventional treatment plus electroacupuncture
Transcranial magnetic group:Conventional treatment plus high-frequency repetitive transcranial magnetic therapy
Joint group:Conventional treatment plus combined treatment

Sponsors

The First Affiliated Hospital of Bengbu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria; 2. The age of first onset is 35-80 years old; 3. Course of disease from 2 weeks to 6 months; 4. According to the modified Ashworth spasm scale, the flexion and elbow tension of the affected limb were less than or equal to level 2; 5. Stable vital signs, clear consciousness, able to carry out treatment instructions and cooperate to complete treatment and evaluation; 6. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with aggravated disease or new lesions; 2. Patients with history of acupuncture needle allergy; 3. Those who cannot complete the evaluation of indicators, such as severe aphasia, severe cognitive impairment, audio-visual impairment, illiteracy, etc.; 4. Complicated with serious primary diseases of cardiovascular, liver, kidney, and hematopoietic system; 5. Other clinical experimenters who are participating in the study and influencing the results of this study; 6. Have a pacemaker or cochlear implant, implant device (e.g. deep brain stimulator, ventriculoperitoneal shunt) or metal in the brain (e.g. aneurysm clip); 7. There is contraindication of rTMS; 8. Withdrawal from the study due to uncontrollable factors.

Design outcomes

Primary

MeasureTime frame
motor evoked potential;sEMG assessment of shoulder related muscles;visual analogue pain rating scale;

Countries

China

Contacts

Public ContactYan Xingzhou

The First Affiliated Hospital of Bengbu Medical College

xzyan70@163.com+86 138 6501 2161

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026